Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Total Current Liabilities (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Total Current Liabilities data on record, last reported at $30.2 million in Q2 2025.

  • For Q2 2025, Total Current Liabilities fell 22.37% year-over-year to $30.2 million; the TTM value through May 2025 reached $30.2 million, down 22.37%, while the annual FY2025 figure was $30.2 million, 22.37% down from the prior year.
  • Total Current Liabilities reached $30.2 million in Q2 2025 per LFCR's latest filing, down from $31.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $195.7 million in Q4 2022 and bottomed at $30.2 million in Q2 2025.
  • Average Total Current Liabilities over 5 years is $86.4 million, with a median of $65.3 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 73.53% in 2022, then plummeted 80.19% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $122.3 million in 2021, then surged by 60.06% to $195.7 million in 2022, then tumbled by 79.43% to $40.3 million in 2023, then dropped by 12.33% to $35.3 million in 2024, then decreased by 14.49% to $30.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $30.2 million in Q2 2025, $31.1 million in Q1 2025, and $35.3 million in Q4 2024.